BioE, Inc. (Formally known as BioErgonomics) Awarded Patent For Cell Separation Compositions Used To Obtain Company’s Category Defining Cord Blood Stem Cell

ST. PAUL, Minn.--(BUSINESS WIRE)--BioE®, Inc., a biomedical company that provides enabling, high-quality cellular tools for drug discovery and therapeutic research, announced today the U.S. Patent and Trademark Office (USPTO) recently awarded it U.S. Patent 7,160,723. This patent — combined with related U.S. Patent 6,933,148 — protects the cell separation compositions for isolating BioE’s Multi-Lineage Progenitor Cell™ (MLPC™) stem cell.